Here’s why brokers are bearish on these ASX shares…
The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia. –
On Monday I looked at three ASX shares brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:
Australia and New Zealand Banking GrpLtd (ASX: ANZ)
According to a note out of Citi, its analysts have retained their sell rating and $28.00 price target on this banking giant’s shares. Although the broker acknowledges that ANZ has the largest exposure to the New Zealand market, it doesn’t expect it to benefit as greatly from rising interest rates as the market may think. In light of this, it sees no reason to make any changes to its rating despite the RBNZ potentially increasing rates soon. The ANZ share price is fetching $27.62 today.
Cochlear Limited (ASX: COH)
Another note out of Citi reveals that its analysts have retained their sell rating and $220.00 price target on this hearing solutions company’s shares. It notes that the University of Pittsburgh has sued Cochlear in the USA for alleged patent infringement. However, the broker doesn’t believe the lawsuit will have a material impact. This is because Cochlear noted that its patents predate the university’s patent by several years. However, it still doesn’t see enough value in its shares at the current level to upgrade its rating. The Cochlear share price is trading at $220.53 today.
Synlait Milk Ltd (ASX: SM1)
Analysts at Macquarie have retained their underperform rating but lifted their price target on this dairy processor’s shares to NZ$3.40 (A$3.27). This follows the release of a disappointing full year result earlier this week. The one positive from the result, though, was that Synlait’s balance sheet was better than it expected. As a result, Macquarie has lifted its price target to reflect the lower balance sheet risk. However, the broker is expecting another tough year in FY 2022 and thus isn’t in a rush to change its rating. The Synlait share price was fetching A$3.51 on Tuesday.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of August 16th 2021
Synlait (ASX:SM1) share price climbs despite largest ever financial loss
September hasn’t been a great month so far for the ANZ (ASX:ANZ) share price
Why ANZ (ASX:ANZ) and this dividend share could be buys
The ANZ (ASX:ANZ) share price is trailing behind the big four today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.